{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:49:25Z","timestamp":1774291765478,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[1999,10,1]]},"DOI":"10.1038\/sj.gt.3301024","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T16:50:10Z","timestamp":1032367810000},"page":"1695-1704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Persistent expression of canine factor IX in hemophilia B canines"],"prefix":"10.1038","volume":"6","author":[{"given":"H","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Samulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D A","family":"Bellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P E","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T C","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C E","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,10,6]]},"reference":[{"key":"BF3301024_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0889-8588(18)30128-X","volume":"8","author":"J Lusher","year":"1994","unstructured":"Lusher J . Transfusion therapy in congenital coagulopathies Hematol Oncol Clin N Am 1994 8: 1167\u20131180","journal-title":"Hematol Oncol Clin N Am"},{"key":"BF3301024_CR2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood.V88.7.2603.bloodjournal8872603","volume":"88","author":"K Brinkhous","year":"1996","unstructured":"Brinkhous K et al. Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B Blood 1996 88: 2603\u20132610","journal-title":"Blood"},{"key":"BF3301024_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1046\/j.1537-2995.1998.38698326337.x","volume":"38","author":"J Soucie","year":"1998","unstructured":"Soucie J et al. Hepatitis A virus infections associated with clotting factor concentrate in the United States Transfusion 1998 38: 573\u2013579","journal-title":"Transfusion"},{"key":"BF3301024_CR4","unstructured":"National Hemophilia Foundation. The treatment of hemophilia and related bleeding disorders, Medical Advisory No. 312. In: Medical and Scientific Advisory Council (MASAC) Recommendations. New York 1998 p 11\u201334"},{"key":"BF3301024_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","volume":"241","author":"T Lofqvist","year":"1997","unstructured":"Lofqvist T, Nilsson I, Berntorp E, Pettersson H . Haemophilia prophylaxis in young patients \u2013 a long-term follow-up J Intern Med 1997 241: 395\u2013400","journal-title":"J Intern Med"},{"key":"BF3301024_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00043426-199123000-00006","volume":"13","author":"P Petrini","year":"1991","unstructured":"Petrini P, Lindvall N, Egberg N, Blomback M . Prophylaxis with factor concentrates in preventing hemophilic arthropathy Am J Pediat Hematol Oncol 1991 13: 280\u2013287","journal-title":"Am J Pediat Hematol Oncol"},{"key":"BF3301024_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.8211118","volume":"262","author":"M Kay","year":"1993","unstructured":"Kay M et al. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient Science 1993 262: 117\u2013119","journal-title":"Science"},{"key":"BF3301024_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1073\/pnas.92.5.1401","volume":"92","author":"Y Dai","year":"1995","unstructured":"Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression Proc Nat Acad Sci USA 1995 92: 1401\u20131405","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF3301024_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0958-1669(98)80031-1","volume":"9","author":"J Rabinowitz","year":"1998","unstructured":"Rabinowitz J, Samulski J . Adeno-associated virus expression system for gene transfer Curr Opin Biotechnol 1998 9: 470\u2013475","journal-title":"Curr Opin Biotechnol"},{"key":"BF3301024_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0065-3527(08)60479-0","volume":"32","author":"K Berns","year":"1987","unstructured":"Berns K, Bohenzky R . Adeno-associated viruses: an update Adv Virus Res 1987 32: 243\u2013306","journal-title":"Adv Virus Res"},{"key":"BF3301024_CR11","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/jvi.70.5.3235-3241.1996","volume":"70","author":"S Afione","year":"1996","unstructured":"Afione S et al. In vivo model of adeno-associated virus vector persistence and rescue J Virol 1996 70: 3235\u20133241","journal-title":"J Virol"},{"key":"BF3301024_CR12","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","volume":"90","author":"T Flotte","year":"1993","unstructured":"Flotte T et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613\u201310617","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301024_CR13","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/jvi.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao X, Li J, Samulski R . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098\u20138108","journal-title":"J Virol"},{"key":"BF3301024_CR14","first-page":"357","volume":"2","author":"T Flotte","year":"1995","unstructured":"Flotte T, Carter B . Adeno-associated virus vectors for gene therapy Gene Therapy 1995 2: 357\u2013362","journal-title":"Gene Therapy"},{"key":"BF3301024_CR15","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","volume":"7","author":"J Dong","year":"1996","unstructured":"Dong J, Fan P, Frizzell R . Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum Gene Ther 1996 7: 2101\u20132112","journal-title":"Hum Gene Ther"},{"key":"BF3301024_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/hum.1997.8.6-659","volume":"8","author":"K Clark","year":"1997","unstructured":"Clark K, Sferra T, Johnson P . Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle Hum Gene Ther 1997 8: 659\u2013669","journal-title":"Hum Gene Ther"},{"key":"BF3301024_CR17","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1073\/pnas.89.8.3357","volume":"89","author":"S Yao","year":"1992","unstructured":"Yao S, Kurachi K . Expression of human factor IX in mice after injection of genetically modified myoblasts Proc Natl Acad Sci USA 1992 89: 3357\u20133361","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301024_CR18","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","volume":"94","author":"R Herzog","year":"1997","unstructured":"Herzog R et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus Proc Nat Acad Sci USA 1997 94: 5804\u20135809","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF3301024_CR19","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.1073\/pnas.86.24.10095","volume":"86","author":"J Evans","year":"1989","unstructured":"Evans J et al. Canine hemophilia B resulting from a point mutation with unusual consequences Proc Nat Acad Sci USA 1989 86: 10095\u201310099","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF3301024_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1055\/s-0038-1656082","volume":"77","author":"D Liles","year":"1997","unstructured":"Liles D et al. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B Thromb Haemostas 1997 77: 944\u2013948","journal-title":"Thromb Haemostas"},{"key":"BF3301024_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.gt.3300548","volume":"5","author":"P Monahan","year":"1998","unstructured":"Monahan P et al. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia Gene Therapy 1998 5: 40\u201349","journal-title":"Gene Therapy"},{"key":"BF3301024_CR22","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1074\/jbc.270.10.5276","volume":"270","author":"S Kurachi","year":"1995","unstructured":"Kurachi S, Hitomi Y, Furukawa M, Kurachi K . Role of intron I in expression of the human factor IX gene J Biol Chem 1995 270: 5276\u20135281","journal-title":"J Biol Chem"},{"key":"BF3301024_CR23","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao X, Li J, Samulski R . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J Virol 1998 72: 2224\u20132232","journal-title":"J Virol"},{"key":"BF3301024_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood.V74.1.207.207","volume":"74","author":"J Evans","year":"1989","unstructured":"Evans J et al. Molecular cloning of a cDNA encoding canine factor IX Blood 1989 74: 207\u2013212","journal-title":"Blood"},{"key":"BF3301024_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/infdis\/161.4.603","volume":"161","author":"L Anderson","year":"1990","unstructured":"Anderson L . Human parvoviruses J Infect Dis 1990 161: 603\u2013608","journal-title":"J Infect Dis"},{"key":"BF3301024_CR26","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","volume":"70","author":"F Ferrari","year":"1996","unstructured":"Ferrari F, Samulski T, Shenk T, Samulski R . Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors J Virol 1996 70: 3227\u20133234","journal-title":"J Virol"},{"key":"BF3301024_CR27","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1073\/pnas.94.13.6916","volume":"94","author":"J Flannery","year":"1997","unstructured":"Flannery J et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus Proc Natl Acad Sci USA 1997 94: 6916\u20136921","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301024_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","volume":"232","author":"I Nilsson","year":"1992","unstructured":"Nilsson I, Berntorp E, Lofqvist T, Pettersson H . Twenty-five years\u2019 experience of prophylactic treatment in severe haemophilia A and B J Intern Med 1992 232: 25","journal-title":"J Intern Med"},{"key":"BF3301024_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/4743","volume":"5","author":"R Herzog","year":"1999","unstructured":"Herzog R et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Nature Med 1999 5: 56\u201363","journal-title":"Nature Med"},{"key":"BF3301024_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/4751","volume":"5","author":"R Snyder","year":"1999","unstructured":"Snyder R et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors Nature Med 1999 5: 64\u201370","journal-title":"Nature Med"},{"key":"BF3301024_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ng0797-270","volume":"16","author":"R Snyder","year":"1997","unstructured":"Snyder R et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 1997 16: 270\u2013276","journal-title":"Nat Genet"},{"key":"BF3301024_CR32","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","volume":"72","author":"C Summerford","year":"1998","unstructured":"Summerford C, Samulski R . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J Virol 1998 72: 1438\u20131445","journal-title":"J Virol"},{"key":"BF3301024_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/4768","volume":"5","author":"C Summerford","year":"1999","unstructured":"Summerford C, Bartlett J, Samulski R . AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection Nature Med 1999 5: 78\u201382","journal-title":"Nature Med"},{"key":"BF3301024_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/4758","volume":"5","author":"K Qing","year":"1999","unstructured":"Qing K et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 Nature Med 1999 5: 71\u201377","journal-title":"Nature Med"},{"key":"BF3301024_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/8470","volume":"5","author":"C Summerford","year":"1999","unstructured":"Summerford C, Samulski R . Viral receptors and vector purification: new approaches for generating clinical-grade reagents Nature Med 1999 5: 587","journal-title":"Nature Med"},{"key":"BF3301024_CR36","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1128\/jvi.71.9.6823-6833.1997","volume":"71","author":"J Chiorini","year":"1997","unstructured":"Chiorini J et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles J Virol 1997 71: 6823\u20136833","journal-title":"J Virol"},{"key":"BF3301024_CR37","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","volume":"93","author":"P Kessler","year":"1996","unstructured":"Kessler P et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci USA 1996 93: 14082\u201314087","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301024_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm0397-306","volume":"3","author":"K Fisher","year":"1997","unstructured":"Fisher K et al. Recombinant adeno-associated virus for muscle directed gene therapy Nature Med 1997 3: 306\u2013312","journal-title":"Nature Med"},{"key":"BF3301024_CR39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/jvi.70.1.520-532.1996","volume":"70","author":"K Fisher","year":"1996","unstructured":"Fisher K et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis J Virol 1996 70: 520\u2013532","journal-title":"J Virol"},{"key":"BF3301024_CR40","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","volume":"72","author":"D Duan","year":"1998","unstructured":"Duan D et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term persistence in muscle tissue J Virol 1998 72: 8568\u20138577","journal-title":"J Virol"},{"key":"BF3301024_CR41","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/JVI.72.4.2777-2787.1998","volume":"72","author":"T Ni","year":"1998","unstructured":"Ni T et al. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection J Virol 1998 72: 2777\u20132787","journal-title":"J Virol"},{"key":"BF3301024_CR42","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/JVI.73.3.1949-1955.1999","volume":"73","author":"N Vincent-Lacaze","year":"1999","unstructured":"Vincent-Lacaze N et al. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle J Virol 1999 73: 1949\u20131955","journal-title":"J Virol"},{"key":"BF3301024_CR43","doi-asserted-by":"publisher","first-page":"16717","DOI":"10.1074\/jbc.272.27.16717","volume":"272","author":"A Wolberg","year":"1997","unstructured":"Wolberg A, Stafford D, Erie D . Human factor IX binds to specific sites on the collagenous domain of collagen IV J Biol Chem 1997 272: 16717\u201316720","journal-title":"J Biol Chem"},{"key":"BF3301024_CR44","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0889-8588(18)30207-7","volume":"7","author":"H Roberts","year":"1993","unstructured":"Roberts H, Eberst M . Current management of hemophilia B Hematol Oncol Clin N Am 1993 7: 1269\u20131280","journal-title":"Hematol Oncol Clin N Am"},{"key":"BF3301024_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/7439","volume":"5","author":"J Greelish","year":"1999","unstructured":"Greelish J et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector Nature Med 1999 5: 439","journal-title":"Nature Med"},{"key":"BF3301024_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nm1197-1295","volume":"3","author":"F Ferrari","year":"1997","unstructured":"Ferrari F, Xiao X, McCarty D, Samulski R . New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors Nature Med 1997 3: 1295\u20131297","journal-title":"Nature Med"},{"key":"BF3301024_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0022-2836(67)90307-5","volume":"26","author":"B Hirt","year":"1967","unstructured":"Hirt B . Selective extraction of polyoma DNA from infected mouse cell cultures J Mol Biol 1967 26: 365\u2013369","journal-title":"J Mol Biol"},{"key":"BF3301024_CR48","first-page":"6.20","volume-title":"In: Nolan C. Molecular Cloning \u2013 a Laboratory Manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch E, Maniatis T . In: Nolan C. Molecular Cloning \u2013 a Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor 1989 pp 6.20\u201321"},{"key":"BF3301024_CR49","first-page":"4.9.1","volume-title":"Current Protocols in Molecular Biology","author":"R Kingston","year":"1997","unstructured":"Kingston R . Analysis of RNA by Northern and slot blot hybridization In: Ausubel F et al (eds) . Current Protocols in Molecular Biology John Wiley & Sons 1997 pp 4.9.1\u20134.9.13"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301024","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:07:57Z","timestamp":1648573677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10,1]]}},"alternative-id":["BF3301024"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301024","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10,1]]},"assertion":[{"value":"28 April 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}